Initial Programs Sample Clauses

Initial Programs. 2.2.1. The Program Plans for the two (2) Initial Programs are attached hereto as Exhibit 2.2.1.
Sample 1Sample 2
AutoNDA by SimpleDocs
Initial Programs. Within [ * ] of the Effective Date, each of the Parties will designate, in writing, its representatives to the Joint Steering Committee ("JSC") and, the parties shall jointly agree upon a schedule of JSC meetings to be held over the next thirty days after the date of designation of the JSC representatives. Within six weeks of the Effective Date, the Parties will develop and agree upon a Workplan that will define: - customer validation, mutually targeted for [ * ] - adaptation of LOCI and a maximum of other chemistries in the Field - development timelines and milestones - the makeup of the Instruments and Oasis LabCard - marketing strategy and resource commitments. Included in the Workplan will be a best estimate production schedule for the delivery of Oasis LabCard chips and for the evaluation of the Instruments, Assay Reagents and Oasis LabCard chips, which production schedule shall be subject to modification by the JSC. Each Party shall commit the necessary resources and diligently strive to achieve its duties under the Workplan in order to facilitate the first commercial sale of a System to a third party, by not later than [ * ]. Until [ * ], neither Party shall divert resources to work on [ * ] for use in combination with Oasis LabCard chips and PACKARD supplied Assay Reagents, if such effort could reasonably be expected to delay the planned commercial launch of a PACKARD supplied System prior to [ * ]. Each Party will bear the cost of its portion of the Development Phase.
Sample 1
Initial Programs. The Parties shall initially establish three Programs (the “Initial Programs). The applicable Product Form for each of the three Initial Programs is set forth on Exhibit A. The Parties understand and agree that the goal of the Initial Programs and this Agreement, as of the Effective Date, is to [**].
Sample 1
Initial Programs. Within [ * ] of the Effective Date, each of the Parties will designate, in writing, its representatives to the Joint Steering Committee ("JSC") and, the parties shall jointly agree upon a schedule of JSC meetings to be held over the next thirty days after the date of designation of the JSC representatives. Within six weeks of the Effective Date, the Parties will develop and agree upon a Workplan that will define: - customer validation, mutually targeted for [ * ] - adaptation of LOCI and a maximum of other chemistries in the Field - development timelines and milestones - the makeup of the Instruments and Oasis LabCard - marketing strategy and resource commitments. Included in the Workplan will be a best estimate production schedule for the delivery of Oasis LabCard chips and for the evaluation of the Instruments, Assay Reagents and Oasis LabCard chips, which production schedule shall be subject to modification by the JSC. Each Party shall commit the necessary resources and diligently strive to achieve its duties under the Workplan in order to facilitate the first commercial sale of a System to a third party, [ * ]. Each Party will bear the cost of its portion of the Development Phase.
Sample 1

Related to Initial Programs

  • Special Programs In consideration of the sale of the Eligible Loans under these Master Sale Terms and each Sale Agreement, Purchaser agrees to cause the Servicer to offer borrowers of Trust Student Loans all special programs whether or not in existence as of the date of any Sale Agreement generally offered to the obligors of comparable loans owned by Xxxxxx Mae subject to the terms and conditions of Section 3.12 of the Servicing Agreement.

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Commercialization Plans As soon as practicable after formation of the JCC (following Acucela’s exercise of an Opt-In Right under Section 3.1), the JCC shall prepare and approve the initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation (and, if applicable, any New Formulation or Other Indication Product) in the Territory. The Parties shall use Commercially Reasonable Efforts to ensure that such initial Commercialization Plan for Commercialization of the Licensed Product for the Initial Indication in the Initial Formulation is consistent with the general Commercialization Plan outline set forth in Exhibit C attached hereto and incorporated herein (the “General Commercialization Plan Outline”). The JCC shall prepare and approve a separate Commercialization Plan for Commercialization of Licensed Product for the Initial Indication in the Initial Formulation in the Territory and for Commercialization of each Other Indication Product and New Formulation (if any) in the Territory, and shall update and amend each Commercialization Plan not less than annually or more frequently as needed to take into account changed circumstances or completion, commencement or cessation of Commercialization activities not contemplated by the then-current Commercialization Plan. Amendments and revisions to the Commercialization Plan shall be reviewed and discussed, in advance, by the JCC, and Otsuka agrees to consider proposals and suggestions made by Acucela regarding amendments and revisions to the Commercialization Plan. Any amendment or revision to the Commercialization Plan that provides for an increase or decrease in the number of FTEs for any Phase 3b Clinical Trials or Post-Approval Studies as compared to the previous version of the Commercialization Plan, or that provides for addition or discontinuation of tasks or activities as compared to the previous version of the Commercialization Plan, or that moves forward the timetable for activities reflected in the Commercialization Plan, shall provide for a reasonable ramp-up or wind-down period, as applicable, to accommodate a smooth and orderly transition of Commercialization activities to the amended or revised Commercialization Plan. Each Commercialization Plan shall identify the goals of Commercialization contemplated thereunder and shall address Commercialization (including Co-Promotion) activities related to the Licensed Product (including, if applicable, any Other Indication Product), including:

  • Marketing Plans 1. The MCO shall develop a marketing plan that meets SDOH guidelines and any local requirements as approved by the State Department of Health (SDOH).

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Compensation Program Amendments Each of the Company’s compensation, bonus, incentive and other benefit plans, arrangements and agreements (including golden parachute, severance and employment agreements) (collectively, “Benefit Plans”) with respect to you is hereby amended to the extent necessary to give effect to provisions (1) and (2). For reference, certain affected Benefit Plans are set forth in Appendix A to this letter. In addition, the Company is required to review its Benefit Plans to ensure that they do not encourage senior executive officers to take unnecessary and excessive risks that threaten the value of the Company. To the extent any such review requires revisions to any Benefit Plan with respect to you, you and the Company agree to negotiate such changes promptly and in good faith.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Development Program A. Development Activities to be Undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Research Neither the Investor nor any Affiliate of the Investor shall have, in the prior thirty (30) days, published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company.

Time is Money Join Law Insider Premium to draft better contracts faster.